Medicus Pharma Accounts Payable Over Time
| MDCX Stock | USD 3.50 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medicus Pharma Performance and Medicus Pharma Correlation. Medicus |
Cross Equities Accounts Payable Analysis
Compare Medicus Pharma and related stocks such as Western Midstream, Enlight Renewable Energy, and Lend Lease Group Accounts Payable Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WES | 6.9 M | 26.6 M | 24.6 M | 39.6 M | 29.1 M | 64.6 M | 123.3 M | 349.8 M | 350.3 M | 293.1 M | 210.7 M | 326.1 M | 360.6 M | 362.5 M | 312.9 M | 170 M |
| ENLT | 4.3 M | 4.3 M | 6.5 M | 35.1 M | 43.7 M | 76.6 M | 36.3 M | 29.2 M | 128.9 M | 119.3 M | 25.6 M | 27.4 M | 10 M | 105.6 M | 589.2 M | 618.7 M |
| ATO | 22 M | 215.2 M | 241.6 M | 311.6 M | 238.9 M | 114.4 M | 233.1 M | 217.3 M | 265 M | 141.1 M | 224.9 M | 258.5 M | 218.2 M | 341.9 M | 393.2 M | 221.6 M |
| BNL | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 20.3 M | 22.3 M | 37.4 M | 74.9 M | 38 M | 47.5 M | 24.5 M | 49 M | 40.5 M |
Medicus Pharma and related stocks such as Western Midstream, Enlight Renewable Energy, and Lend Lease Group Accounts Payable description
An accounting item on the balance sheet that represents Medicus Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Medicus Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.My Equities
My Current Equities and Potential Positions
Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.